Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors

First-in-human non-viral TCR-T cell therapy targeting shared hotspot mutations in solid cancers First clinical product manufactured and administered to a patient using the Company's in house cGMP manufacturing facility Expect to report initial data in